Blood Cell Technologies, LLC is an early-stage research and development biotechnology company and resident of JLABS@NYC. We are focused on the identification, validation and commercialization of novel drug targets and compounds that may be used to diagnose or treat disease. This is accomplished by identifying novel cellular targets, targeted drug development and novel biomarker development. Areas of interest include hematology, metabolism, antioxidants and cancer.
Company Details
- Employees
- 3
- Address
- 101 6th Ave, New York,ny 10013,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- New York, NY
Blood Cell Technologies Questions
Blood Cell Technologies's website is http://www.bloodcelltechnologies.com
Blood Cell Technologies's LinkedIn profile is https://www.linkedin.com/company/blood-cell-technologies
Blood Cell Technologies has
3 employees.
View email and phone details for 3
employees at Blood Cell Technologies.
Blood Cell Technologies's industry is
Biotechnology Research
Blood Cell Technologies's top competitors are
Chemitope Glycopeptide, Inc.,
Ionuvox Research And Development,
Sparian Biosciences,
Micoy Therapeutics,
Brown Medicine,
Pharmacelera,
Bridge Medicines Llc,
Alpha-1 Biologics,
Novita Pharmaceuticals,
Grit Bio, Inc..
Blood Cell Technologies's categories are Biotechnology Research
